- AU$12.35m
- AU$15.41m
- AU$0.27m
Australia Stock Exchange release from MEMPHASYS : First Felix System commercial sale for clinical IVF use
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 12:16:57
Australia Stock Exchange release from MEMPHASYS : Memphasys & Monash IVF commence clinical trial of FELIX
Australia Stock Exchange release from MEMPHASYS : SAMSON stallion fertility device used in field trials
Australia Stock Exchange release from MEMPHASYS : Change of Director's Interest Notice AC
Australia Stock Exchange release from MEMPHASYS : Results of Meeting
Australia's Memphasys hits 10-month high on device sale to Chinese manufacturer
Australia Stock Exchange release from MEMPHASYS : First Sale of FelixTM in Research Application
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 09:17:00
Australia's Memphasys at 8-month high on assessment results for medical device
Australia Stock Exchange release from MEMPHASYS : Verification and Validation Assessments Complete
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 10:10:39
Australia Stock Exchange release from MEMPHASYS : Notification of cessation of securities - MEM
Australia Stock Exchange release from MEMPHASYS : MEM receives $1.36m R&D tax rebate
Australia Stock Exchange release from MEMPHASYS : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from MEMPHASYS : PRE_NR Ends: 08:58:50
Australia Stock Exchange release from MEMPHASYS : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from MEMPHASYS : Cleansing Notice - Section 708A(5)(e)
Australia Stock Exchange release from MEMPHASYS : Application for quotation of securities - MEM